Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

RISING

  • FDA Approval
  • June 18, 2024, 15:38 UTC
  • 48
  • 0 comments

FDA approve ORPHENADRINE CITRATE

Comment Full text

MYLAN

  • FDA Approval
  • June 17, 2024, 09:18 UTC
  • 49
  • 0 comments

FDA approve ZALEPLON

Comment Full text

ZYDUS PHARMS USA INC

  • FDA Approval
  • June 17, 2024, 09:18 UTC
  • 47
  • 0 comments

FDA approve VENLAFAXINE HYDROCHLORIDE

Comment Full text

UPSHER SMITH LABS

  • FDA Approval
  • June 17, 2024, 09:18 UTC
  • 50
  • 0 comments

FDA approve DOXAZOSIN MESYLATE

Comment Full text

APOTEX

  • FDA Approval
  • June 17, 2024, 09:18 UTC
  • 46
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text

ZYDUS LIFESCIENCES

  • FDA Approval
  • June 17, 2024, 09:18 UTC
  • 43
  • 0 comments

FDA approve EFINACONAZOLE

Comment Full text

BAXTER HLTHCARE

  • FDA Approval
  • June 14, 2024, 16:54 UTC
  • 41
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

WANBANG BIOPHARMS

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 42
  • 0 comments

FDA approve GUANFACINE HYDROCHLORIDE

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 40
  • 0 comments

FDA approve NAPROXEN

Comment Full text

BIOCRYST

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 38
  • 0 comments

FDA approve PERAMIVIR

Comment Full text
  • Previous
  • 418
  • 419
  • 420
  • 421
  • 422
  • Next

Search

News categories

  • Technical Exchange News(11639)
  • Event(3907)
  • SEC News(228334)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(140712)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin